CORC

在结果中检索

CORC

浏览/检索结果: 共10条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation 期刊论文
ONCOGENESIS, 2021, 卷号: 10
作者:  Fan, Xiaoqing;  Fan, Junqi;  Yang, Haoran;  Zhao, Chenggang;  Niu, Wanxiang
收藏  |  浏览/下载：41/0  |  提交时间：2021/11/29
Integrative Proteomic Characterization of Human Lung Adenocarcinoma 期刊论文
CELL, 2020, 卷号: 182, 期号: 1, 页码: 245-+
作者:  Xu, Jun-Yu;  Zhang, Chunchao;  Wang, Xiang;  Zhai, Linhui;  Ma, Yiming
收藏  |  浏览/下载：52/0  |  提交时间：2020/12/24
EGFR exon 20 insertion mutations in non-small cell lung cancer 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Wang, Fenfang;  Li, Chenghui;  Wu, Qihuan;  Lu, Hongyang
收藏  |  浏览/下载：20/0  |  提交时间：2020/11/26
Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma 期刊论文
ONCOLOGY LETTERS, 2018, 卷号: 16, 期号: 6, 页码: 7057-7067
作者:  Li, Ming;  Li, Chuanying;  Ke, Li;  Zhan, Mali;  Cheng, Min
收藏  |  浏览/下载：240/0  |  提交时间：2019/06/20
Significance of the epidermal growth factor receptor mutation status and differences among molecular subgroups in surgically resected lung microinvasive adenocarcinoma 期刊论文
Oncology letters, 2018, 卷号: 16, 期号: 6, 页码: 7057-7067
作者:  Li, Ming;  Li, Chuanying;  Ke, Li;  Zhan, Mali;  Cheng, Min
收藏  |  浏览/下载：134/0  |  提交时间：2019/05/08
Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study 期刊论文
2017, 卷号: 15, 期号: 1, 页码: 197
作者:  Yang, Wenjing;  Gao, Yibo;  Li, Xuelian;  Zhang, Jing;  Liu, Tiejun
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma 期刊论文
Pathology oncology research : POR, 2014, 卷号: 20, 期号: 2, 页码: 445-451
作者:  Lu, Rong-li;  Hu, Cheng-Ping*;  Yang, Hua-ping;  Li, Yuan-yuan;  Gu, Qi-hua
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma 期刊论文
ONCOTARGETS AND THERAPY, 2014, 卷号: 7, 期号: 1, 页码: 1423-1437
作者:  Hu, HC;  Pan, YJ;  Li, Y;  Wang, L;  Wang, R
收藏  |  浏览/下载：63/0  |  提交时间：2015/07/22
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma 期刊论文
EUROPEAN RESPIRATORY JOURNAL, 2012, 卷号: 39, 期号: 2, 页码: 366-372
作者:  Girard, N;  Sima, CS;  Jackman, DM;  Sequist, LV;  Chen, H
收藏  |  浏览/下载：18/0  |  提交时间：2015/07/22
Efficacy Outcomes in First-line Treatment of Advanced NSCLC With Gefitinib (G) vs Carboplatin/paclitaxel (C/P) by Epidermal Growth Factor Receptor (EGFR) Gene-copy Number Score and by Most Common EGFR Mutation Subtypes - Exploratory Data From IPA 会议论文
EUROPEAN JOURNAL OF CANCER, 2011-09-01
作者:  Yang, J.;  Wu, Y. L.;  Saijo, N.;  Thongprasert, S.;  Chu, D. T.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace